Marshall Wace North America’s Xylem XYL Stock Holding History

Marshall Wace North America’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,620	Closed	-$805K	–	1581
2019 Q2	$805K	Buy	+9,620	New	+$767K	0.01%	801
2018 Q2	–	Sell	-8,742	Closed	-$672K	–	1743
2018 Q1	$672K	Buy	+8,742	New	+$646K	﹤0.01%	1093
2017 Q4	–	Sell	-362,673	Closed	-$22.8M	–	1644
2017 Q3	$22.8M	Sell	362,673 -894,695	-71%	-$53.5M	0.14%	189
2017 Q2	$69.2M	Buy	1,257,368 +164,915	+15%	+$8.59M	0.51%	38
2017 Q1	$54.6M	Buy	+1,092,453	New	+$53.2M	0.43%	57
2013 Q4	–	Sell	-40,041	Closed	-$1.12M	–	852
2013 Q3	$1.12M	Buy	+40,041	New	+$1.07M	0.03%	329

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's XYL Position: Q3 2019 in Review

Marshall Wace North America sold out of Xylem (XYL) in Q3 2019, closing a stake of 9,620 shares — an estimated $805K sold.

Marshall Wace North America first reported a position in XYL in Q3 2013 and held it in 6 quarters. The position peaked at $69.2M in Q2 2017. 678 funds tracked by Wall St. Rank hold XYL as of Q3 2019.

Marshall Wace North America reported no remaining Xylem position as of Q3 2019 after selling out during the quarter.
Marshall Wace North America sold 9,620 Xylem shares in Q3 2019, an estimated $805K.
Marshall Wace North America first reported a position in Xylem in Q3 2013 and held it in 6 quarters.
Marshall Wace North America's Xylem position peaked at $69.2M in Q2 2017.
678 funds tracked by Wall St. Rank held Xylem as of Q3 2019.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.